Grace Therapeutics (GRCE) vs Lite Strategy (LITS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Grace Therapeutics (GRCE) has outperformed Lite Strategy (LITS) over the past year, losing 30.5% versus a loss of 48.2%. Over five years, GRCE leads with a -79.9% price change compared with -97.8% for LITS. Grace Therapeutics is the larger company by market cap ($42.5 million vs $36.5 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GRCE | LITS |
|---|---|---|
| Share price | $2.02 | $1.20 |
| Market cap | $42.49M | $36.49M |
| 1-day change | -3.81% | -5.50% |
| YTD return | -39.31% | -3.79% |
| 1-year return | -30.46% | -48.16% |
| 5-year return | -79.89% | -97.82% |
| EPS (TTM) | $-1.17 | $-2.06 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $5.18 | $2.97 |
| 52-week low | $1.79 | $0.69 |
| Distance from 52-week high | -61.00% | -59.59% |
| Average volume | 171.87K | 448.62K |
| Shares outstanding | 21.04M | 30.41M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- GRCE has outperformed LITS by 17.7 percentage points over the past year.
GRCE vs LITS FAQ
Which is bigger, Grace Therapeutics or Lite Strategy?
Grace Therapeutics (GRCE) is larger, with a market capitalization of $42.49M compared with $36.49M for Lite Strategy (LITS).
Which stock has performed better over the past year, GRCE or LITS?
GRCE returned -30.46% over the past 12 months, compared with -48.16% for LITS (price return, excluding dividends). Past performance does not predict future results.
Are Grace Therapeutics and Lite Strategy in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.